Skip to content
August 10, 2022

Equity.Guru

Investment information for the new generation

quick to cash

On May 31, 2021 Aequus Pharmaceuticals (AQS.V) reported financial results for Q1, 2021.   Aequus is a $19 million pharmaceutical company focused on developing and commercializing high quality, differentiated…
Aequus is a $24 million pharmaceutical company focused on developing and commercializing high quality, differentiated products….
Currently in Canada, the dry eye market is estimated at over $9O million, which includes both prescription and over-the-counter products….